Skip to content

Probiscend

Navigating Justice, Empowering Voices

  • Institutional Review Boards
  • Medicare Part D
  • Prescription Monitoring Programs
  • Food Drug and Cosmetic Act
  • Controlled Substances Act
  • Patient Safety Organization Standards
  • Telemedicine Regulation

Probiscend

Navigating Justice, Empowering Voices

  • Institutional Review Boards
  • Medicare Part D
  • Prescription Monitoring Programs
  • Food Drug and Cosmetic Act
  • Controlled Substances Act
  • Patient Safety Organization Standards
  • Telemedicine Regulation
Patent Term Extension
March 18, 2024 ProbiScend Team

Understanding Patent Term Extension and Patent Rights Duration in Legal Contexts

Patent rights are vital for safeguarding innovation and encouraging research, yet their duration remains a complex legal subject. Understanding the

Read More
Hatch Waxman Act
March 18, 2024 ProbiScend Team

Assessing the Impact of Hatch Waxman on Drug Prices and Market Competition

The Hatch Waxman Act of 1984 significantly reshaped the pharmaceutical landscape by balancing innovation incentives with efforts to reduce drug

Read More
Orphan Drug Act
March 18, 2024 ProbiScend Team

Understanding Orphan Drug Designation and Clinical Trial Strategies

The orphan drug designation, established under the Orphan Drug Act, plays a crucial role in accelerating the development of therapies

Read More
Food Drug and Cosmetic Act
March 18, 2024 ProbiScend Team

Understanding Liability Issues in Food and Drug Manufacturing Processes

Liability issues in food and drug manufacturing present significant legal challenges that directly impact consumer safety and industry compliance. Understanding

Read More
Hatch Waxman Act
March 18, 2024 ProbiScend Team

Understanding Pay-for-Delay Patent Settlements and Their Legal Implications

Pay-for-delay patent settlements, often scrutinized within the framework of the Hatch-Waxman Act, raise critical questions about their influence on market

Read More
Biologics License Application
March 18, 2024 ProbiScend Team

Essential Guidelines for BLA Documentation at Manufacturing Sites

Proper documentation is fundamental to ensuring manufacturing site compliance within the biologics industry. Accurate and comprehensive BLA documentation for manufacturing

Read More
Patent Term Extension
March 18, 2024 ProbiScend Team

Analyzing the Impact of Patent Term Extension on Innovation and Patent Policy

The impact of patent term extension on innovation remains a critical topic within legal and industrial spheres. As countries extend

Read More
Biosimilar Regulation
March 18, 2024 ProbiScend Team

Understanding FDA Biosimilar Application Requirements for Legal Compliance

Understanding the FDA biosimilar application requirements is essential for navigating the complex landscape of biosimilar regulation. Proper adherence ensures approved

Read More
Orphan Drug Act
March 17, 2024 ProbiScend Team

Understanding the Role of Orphan Drug Designation in Rare Disease Research

The Orphan Drug Act has played a pivotal role in transforming rare disease research by incentivizing the development of therapies

Read More
Hatch Waxman Act
March 17, 2024 ProbiScend Team

Understanding Patent Settlement Agreements: Key Legal Insights and Implications

Patent settlement agreements play a critical role in resolving disputes within intellectual property law, often shaping the trajectory of patent

Read More
  • ← Previous
  • Next →
  • About
  • Contact Us
  • Privacy Policy
  • Disclaimer
  • Terms & Conditions